These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19519501)

  • 1. Thalidomide chemotherapy-induced peripheral neuropathy: actual status and new perspectives with thalidomide analogues derivatives.
    Cundari S; Cavaletti G
    Mini Rev Med Chem; 2009 Jun; 9(7):760-8. PubMed ID: 19519501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse effects of thalidomide administration in patients with neoplastic diseases.
    Dimopoulos MA; Eleutherakis-Papaiakovou V
    Am J Med; 2004 Oct; 117(7):508-15. PubMed ID: 15464708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide neuropathy: too much or too long?
    Apfel SC; Zochodne DW
    Neurology; 2004 Jun; 62(12):2158-9. PubMed ID: 15210874
    [No Abstract]   [Full Text] [Related]  

  • 4. Thalidomide-induced neuropathy.
    Crawford CL
    Mayo Clin Proc; 2002 Dec; 77(12):1395; author reply 1395. PubMed ID: 12479531
    [No Abstract]   [Full Text] [Related]  

  • 5. Vinca alkaloids, thalidomide and eribulin-induced peripheral neurotoxicity: From pathogenesis to treatment.
    Islam B; Lustberg M; Staff NP; Kolb N; Alberti P; Argyriou AA
    J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2():S63-S73. PubMed ID: 31647152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy-induced peripheral neuropathy: Symptomatology and epidemiology].
    Kerckhove N; Collin A; Condé S; Chaleteix C; Pezet D; Balayssac D; Guastella V
    Bull Cancer; 2018 Nov; 105(11):1020-1032. PubMed ID: 30244980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of multiple myeloma: thalidomide-, bortezomib-, and lenalidomide-induced peripheral neuropathy.
    Koeppen S
    Oncol Res Treat; 2014; 37(9):506-13. PubMed ID: 25231692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory drugs.
    Crane E; List A
    Cancer Invest; 2005; 23(7):625-34. PubMed ID: 16305990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide-induced perioral neuropathy.
    Elad S; Galili D; Garfunkel AA; Or R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Oct; 84(4):362-4. PubMed ID: 9347498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory analogues of thalidomide in the treatment of multiple myeloma.
    Suppiah R; Srkalovic JG; Hussein MA
    Clin Lymphoma Myeloma; 2006 Jan; 6(4):301-5. PubMed ID: 16507207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-Induced Peripheral Neuropathy Treated with Dorsal Root Ganglion Stimulation.
    Groenen PS; van Helmond N; Chapman KB
    Pain Med; 2019 Apr; 20(4):857-859. PubMed ID: 30412243
    [No Abstract]   [Full Text] [Related]  

  • 12. Thalidomide-induced neuropathy: treatment by decompression of peripheral nerves.
    Rose MI; Rosson GD; Elkwood AI; Dellon AL
    Plast Reconstr Surg; 2006 Jun; 117(7):2329-32. PubMed ID: 16772938
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy-induced peripheral neurotoxicity.
    Cavaletti G; Marmiroli P
    Expert Opin Drug Saf; 2004 Nov; 3(6):535-46. PubMed ID: 15500413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalidomide neuropathy: role of F-wave monitoring.
    Rao DG; Kane NM; Oware A
    Muscle Nerve; 2000 Aug; 23(8):1301-2. PubMed ID: 10918274
    [No Abstract]   [Full Text] [Related]  

  • 15. Thalidomide neurotoxicity: prospective study in patients with lupus erythematosus.
    Briani C; Zara G; Rondinone R; Della Libera S; Ermani M; Ruggero S; Ghirardello A; Zampieri S; Doria A
    Neurology; 2004 Jun; 62(12):2288-90. PubMed ID: 15210897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide-induced orofacial neuropathy.
    Anyanwu CO; Stewart CL; Werth VP
    J Clin Rheumatol; 2014 Oct; 20(7):399-400. PubMed ID: 25275775
    [No Abstract]   [Full Text] [Related]  

  • 17. IMiDs: a novel class of immunomodulators.
    Knight R
    Semin Oncol; 2005 Aug; 32(4 Suppl 5):S24-30. PubMed ID: 16085014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance Therapy With Immunomodulatory Drugs in Multiple Myeloma: A Meta-Analysis and Systematic Review.
    Wang Y; Yang F; Shen Y; Zhang W; Wang J; Chang VT; Andersson BS; Qazilbash MH; Champlin RE; Berenson JR; Guan X; Wang ML
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26582244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide analogues as anticancer drugs.
    Aragon-Ching JB; Li H; Gardner ER; Figg WD
    Recent Pat Anticancer Drug Discov; 2007 Jun; 2(2):167-74. PubMed ID: 17975653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel immunomodulatory compounds in multiple myeloma.
    Saini N; Mahindra A
    Expert Opin Investig Drugs; 2013 Feb; 22(2):207-15. PubMed ID: 23265189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.